ERBB3 G284R

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

ERBB3 G284R	Urothelial Cancer	ERBB3 G284R	Urothelial Cancer	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3
ERBB3 G284R	HER2 Negative Breast Cancer	ERBB3 G284R	HER2 Negative Breast Cancer	trastuzumab + lapatinib Sensitive: C4 – Case Studies trastuzumab + lapatinib Sensitive : C4	trastuzumab + lapatinib Sensitive: C4 – Case Studies trastuzumab + lapatinib Sensitive : C4

Associations